We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Researchers Determine Predicting Factors of Positive Lung Cancer Diagnoses in Chest X-Rays

By MedImaging International staff writers
Posted on 17 Jun 2009
A study determined several predictors of a positive lung cancer diagnosis after having an abnormal chest radiograph.

Dr. Martin Carl Tammemag, from Brock University (St. Catharine's, Ontario, Canada), and his team of US researchers from Georgetown University (Washington DC, USA) and the University of Minnesota (Minneapolis–St. Paul, USA) examined the chest radiographs of 12,314 individuals obtained through the U.S. National Cancer Institute's (NCI; Bethesda, MD, USA) Prostate Lung Colorectal Ovarian Cancer Screening Trial (PLCO). They found that older age, lower education levels, and a longer smoking history were all associated with a true-positive diagnosis for lung cancer in those individuals with an abnormal screening chest radiograph.

A true positive chest X-ray represents an accurate reading for lung cancer. Other factors that contributed to a true-positive diagnosis include a family history of lung cancer and a suspicious mass in the upper/middle chest region.

"The factors will be particularly valuable to those health care providers and clinicians identifying patients with abnormal chest X-rays that might indicate possible lung cancer,” said Dr. Tammemag. "An earlier diagnosis is expected to lead to a more favorable outcome for the patient, so it is our hope that predictors will assist clinicians in calling for the most necessary and timely tests.”

The study's findings were published in the June 2009 issue of the Journal of Thoracic Oncology.

Related Links:
Brock University
Georgetown University
University of Minnesota
U.S. National Cancer Institute

Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Breast Localization System
MAMMOREP LOOP
Ultrasound-Guided Biopsy & Visualization Tools
Endoscopic Ultrasound (EUS) Guided Devices
Digital Intelligent Ferromagnetic Detector
Digital Ferromagnetic Detector

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.